Revision as of 11:00, 2 December 2010 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Script assisted update of identifiers from ChemSpider, CommonChemistry and FDA for the Chem/Drugbox validation project - Updated: InChI1->InChI StdInChI StdInChIKey.← Previous edit |
Latest revision as of 19:56, 23 September 2024 edit undoJWBE (talk | contribs)Extended confirmed users10,111 edits removed Category:Phenylmorpholines; added Category:Morpholines using HotCat |
(41 intermediate revisions by 28 users not shown) |
Line 1: |
Line 1: |
|
|
{{Short description|Chemical compound}} |
|
{{Drugbox |
|
{{Drugbox |
|
|
| Verifiedfields = changed |
⚫ |
| IUPAC_name = (2''S'',2'''S'')-2,2'-biphenyl-4,4'-diyl''bis''(2-hydroxy-4,4-dimethylmorpholin-4-ium) |
|
|
|
| Watchedfields = changed |
⚫ |
| image = Hemicholinium-3.svg |
|
|
|
| verifiedrevid = 400103507 |
⚫ |
| InChI = 1/C24H34N2O4.2BrH/c1-25(2)13-15-29-23(27,17-25)21-9-5-19(6-10-21)20-7-11-22(12-8-20)24(28)18-26(3,4)14-16-30-24;;/h5-12,27-28H,13-18H2,1-4H3;2*1H/q+2;;/p-2 |
|
|
⚫ |
| IUPAC_name = (2''S'',2''S'')-2,2'-biphenyl-4,4'-diyl''bis''(2-hydroxy-4,4-dimethylmorpholin-4-ium) |
⚫ |
| InChIKey = OPYKHUMNFAMIBL-NUQVWONBAD |
|
|
⚫ |
| image = Hemicholinium-3.svg |
|
| StdInChI = 1S/C24H34N2O4.2BrH/c1-25(2)13-15-29-23(27,17-25)21-9-5-19(6-10-21)20-7-11-22(12-8-20)24(28)18-26(3,4)14-16-30-24;;/h5-12,27-28H,13-18H2,1-4H3;2*1H/q+2;;/p-2 |
|
|
|
| alt = Skeletal formula |
|
| StdInChIKey = OPYKHUMNFAMIBL-UHFFFAOYSA-L |
|
|
|
| width = 260 |
⚫ |
| CAS_number = 312-45-8 |
|
|
|
| image2 = Hemicholinium-3 cation spacefill.png |
⚫ |
| ATC_prefix = None |
|
|
|
| alt2 = Space-filling model of the hemicholinium-3 cation |
⚫ |
| ATC_suffix = |
|
|
|
|
|
|
<!--Clinical data--> |
|
|
| tradename = |
|
⚫ |
| legal_status = |
|
⚫ |
| routes_of_administration = |
|
|
|
|
|
<!--Pharmacokinetic data--> |
|
⚫ |
| bioavailability = |
|
⚫ |
| metabolism = |
|
⚫ |
| elimination_half-life = |
|
⚫ |
| excretion = |
|
|
|
|
|
<!--Identifiers--> |
|
|
| IUPHAR_ligand = 4493 |
|
|
| CAS_number_Ref = {{cascite|correct|??}} |
|
⚫ |
| CAS_number = 312-45-8 |
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
|
| UNII = 65NY3I7ZD0 |
|
⚫ |
| ATC_prefix = None |
|
⚫ |
| ATC_suffix = |
|
| PubChem = 9399 |
|
| PubChem = 9399 |
|
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID = 9029 |
|
| ChemSpiderID = 9029 |
|
|
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
⚫ |
| C = 24 | H = 34 | N = 2 | O = 4 <sup>+2</sup> |
|
|
|
| ChEMBL = 268697 |
|
| molecular_weight = 414.538 g/mol |
|
|
|
|
|
|
<!--Chemical data--> |
|
⚫ |
| C=24 | H=34 | N=2 | O=4 |charge=2+ |
|
| smiles = ..OC1(OCC(C)(C)C1)c2ccc(cc2)c3ccc(cc3)C4(O)OCC(C)(C)C4 |
|
| smiles = ..OC1(OCC(C)(C)C1)c2ccc(cc2)c3ccc(cc3)C4(O)OCC(C)(C)C4 |
|
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
⚫ |
| synonyms = <small>2-phenyl]-4,4-dimethylmorpholin-4-ium-2-ol</small> |
|
|
⚫ |
| StdInChI = 1S/C24H34N2O4.2BrH/c1-25(2)13-15-29-23(27,17-25)21-9-5-19(6-10-21)20-7-11-22(12-8-20)24(28)18-26(3,4)14-16-30-24;;/h5-12,27-28H,13-18H2,1-4H3;2*1H/q+2;;/p-2 |
⚫ |
| bioavailability = |
|
|
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
⚫ |
| metabolism = |
|
|
⚫ |
| StdInChIKey = OPYKHUMNFAMIBL-UHFFFAOYSA-L |
⚫ |
| elimination_half-life = |
|
|
⚫ |
| synonyms = <small>2-phenyl]-4,4-dimethylmorpholin-4-ium-2-ol</small> |
⚫ |
| excretion = |
|
⚫ |
| legal_status = |
|
⚫ |
| routes_of_administration = |
|
|
}} |
|
}} |
|
|
|
|
|
'''Hemicholinium-3''' ('''HC3'''), also known as '''hemicholine''', is a ] which blocks the ] of ] by the high affinity transporter ChT (encoded in humans by the gene ]) at the ]. The reuptake of choline is the ] in the synthesis of ]; hence, hemicholinium-3 decreases the synthesis of acetylcholine. It is therefore classified as an ] ].<ref name="Carlson">{{cite book | first= Neil R. | last= Carlson | year= 2007 | title= Physiology of Behavior, 9th ed. | location= Boston | publisher=Pearson Education, Inc. | isbn= 0-205-46724-5 | page= 117}}</ref> |
|
'''Hemicholinium-3''' ('''HC3'''), also known as '''hemicholine''', is a ] which blocks the ] of ] by the high-affinity ] (ChT; encoded in humans by the gene ''SLC5A7'') at the ]. The reuptake of choline is the ] in the synthesis of ]; hence, hemicholinium-3 decreases the synthesis of acetylcholine. It is therefore classified as an ] ].<ref name="Carlson">{{cite book | first= Neil R. | last= Carlson | name-list-style = vanc | year= 2007 | title= Physiology of Behavior | edition=9th | location= Boston | publisher=Pearson Education, Inc. | isbn= 978-0-205-46724-2 | page= 117}}</ref> |
|
|
|
|
|
Acetylcholine is synthesized from choline and a donated ] group from ], by the action of ] (ChAT). Thus, decreasing the amount of choline available to a neuron will decrease the amount of acetylcholine produced. Neurons affected by hemicholinium-3 must rely on the transport of choline from the ] (cell body), rather than relying on reuptake of choline from the synaptic cleft. |
|
Acetylcholine is synthesized from choline and a donated ] group from ], by the action of ] (ChAT). Thus, decreasing the amount of choline available to a neuron will decrease the amount of acetylcholine produced. Neurons affected by hemicholinium-3 must rely on the transport of choline from the ] (cell body), rather than relying on reuptake of choline from the synaptic cleft. |
|
|
|
|
|
|
==Toxicity== |
|
Hemicholinium-3 is frequently used as a research tool in animal and ] experiments. |
|
|
|
Hemicholinium-3 is highly toxic because it interferes with cholinergic neurotransmission. The LD50 of hemicholinium-3 for mice is about 35 μg.<ref>{{cite journal | vauthors = Freeman JJ, Kosh JW, Parrish JS | title = Peripheral toxicity of hemicholinium-3 in mice | journal = British Journal of Pharmacology | volume = 77 | issue = 2 | pages = 239–44 | date = October 1982 | pmid = 7139185 | pmc = 2044599 | doi = 10.1111/j.1476-5381.1982.tb09291.x }}</ref> |
|
|
|
|
|
== See also == |
|
== See also == |
|
* ] |
|
*] |
|
|
*] |
|
|
|
|
|
== References == |
|
== References == |
|
{{Reflist}} |
|
{{Reflist}} |
|
|
{{Commons cat}} |
|
|
{{Acetylcholine metabolism and transport modulators}} |
|
|
|
|
|
⚫ |
] |
|
|
|
|
{{Cholinergics}} |
|
|
|
|
⚫ |
] |
|
|
] |
|
] |
|
] |
|
] |
|
|
] |
|
|
] |